Investigating why a new brain cancer drug works in some patients but not others

Dr Kerrie McDonald

UNSW Sydney (NSW)

$352,266

2013 - 2015

‍

The Research

High expression levels of the tumour suppressor gene MIG-6 was associated with better survival in a group of glioblastoma patients treated with bevacizumab